Karst Peak Capital

Karst Peak Capital

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

Hong Kong, Hong Kong


The VC's location is in Asia, Hong Kong. The the headquarters of this VC is in Hong Kong.

Among the most popular portfolio start-ups of the fund, are Treebo Hotels, Tessa Therapeutics. We can highlight the most popular investment areas for this fund, such as Hospitality, Biotechnology. In addition, there are 4 more industries where it has achieved success. Moreover, a start-up needs to be 6-10 years old to get investment from this fund. The fund has no a preferred number of founders for start-ups that it invests in. The country of its establishment and the country of its most frequent investments doesn't coincide - Singapore. However, start-ups from 1 other country can be found in the fund's portfolio.

Typical investments for this fund are deals in the range of 50 - 100 millions dollars. The fund usually participates in less than 2 investment rounds per year. In 2017, the fund's activity was at its peak.

The fund typically invests in rounds with 4-5 participants. Besides Karst Peak Capital, start-ups are typically funded by SAIF Partners, Matrix Partners India, Bertelsmann India Investments. The most common co-investors for the fund are Ward Ferry Management, Temasek Holdings, SAIF Partners. In subsequent rounds, the fund is usually joined by InnoVen Capital.

Fund Activity

Not operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: peakcapital.nl; User name format in descending order of probability: first_initial last, first

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Funds Investing in Following

InnoVen Capital

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: